ET INTELLIGENCE GROUP

Fosun to pare stake in Gland Pharma

​​​This represents the second instance where the promoter is reducing its stake in the company, following a successful initial public offering in November 2020 that raised ₹6,479 crore, including an offer for sale of ₹5,229 crore by the company's promoter. Post